跳到正文
Daniel Castellano· @cdanicas · X·· 2 天前评分70

KN-866

正文 · 原文

🎯 Starting the GU oral session! #ESMO26 @JensBedke presented the ph3 study in MIBC KN-866
A negative study of Cis-Gem + Pembro vs Cis-Gem periop.🤷‍♂️
What about NIAGARA study? 🤨 @OncoAlert @myESMO @DrFelixGuerrero @GuardConsortium @UroTarget

381 浏览 · 11 赞 · 8 转发 · 0 回复

来源:Daniel Castellano · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org